| Literature DB >> 21256666 |
Andrew R Carson1, Charles F McTiernan, Linda Lavery, Abigail Hodnick, Michelle Grata, Xiaoping Leng, Jianjun Wang, Xucai Chen, Ruth A Modzelewski, Flordeliza S Villanueva.
Abstract
When microbubble contrast agents are loaded with genes and systemically injected, ultrasound-targeted microbubble destruction (UTMD) facilitates focused delivery of genes to target tissues. A mouse model of squamous cell carcinoma was used to test the hypothesis that UTMD would specifically transduce tumor tissue and slow tumor growth when treated with herpes simplex virus thymidine kinase (TK) and ganciclovir. UTMD-mediated delivery of reporter genes resulted in tumor expression of luciferase and green fluorescent protein (GFP) in perivascular areas and individual tumor cells that exceeded expression in control tumors (p=0.02). The doubling time of TK-treated tumors was longer than GFP-treated tumors (p=0.02), and TK-treated tumors displayed increased apoptosis (p=0.04) and more areas of cellular drop-out (p=0.03). These data indicate that UTMD gene therapy can transduce solid tumors and mediate a therapeutic effect. UTMD is a promising nonviral method for targeting gene therapy that may be useful in a spectrum of tumors.Entities:
Mesh：
Substances：
Year: 2011 PMID： 21256666 PMCID： PMC4111473 DOI： 10.1016/j.ultrasmedbio.2010.11.011
Source DB: PubMed Journal: Ultrasound Med Biol ISSN： 0301-5629 Impact factor: 2.998